Multisystem inflammatory syndrome in children in New York State
…, W Pulver, L Smith, B Hutton, D Blog… - … England Journal of …, 2020 - Mass Medical Soc
Background A multisystem inflammatory syndrome in children (MIS-C) is associated with
coronavirus disease 2019. The New York State Department of Health (NYSDOH) established …
coronavirus disease 2019. The New York State Department of Health (NYSDOH) established …
[HTML][HTML] Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York State
…, P Weinberg, J Kirkwood, A Muse, J DeHovitz, DS Blog… - Jama, 2020 - jamanetwork.com
Importance Hydroxychloroquine, with or without azithromycin, has been considered as a
possible therapeutic agent for patients with coronavirus disease 2019 (COVID-19). However, …
possible therapeutic agent for patients with coronavirus disease 2019 (COVID-19). However, …
Seroprevalence of antibodies to SARS-CoV-2 in 10 sites in the United States, March 23-May 12, 2020
…, V Semenova, C Blackmore, D Blog… - JAMA internal …, 2020 - jamanetwork.com
Importance Reported cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection likely underestimate the prevalence of infection in affected communities. Large-…
infection likely underestimate the prevalence of infection in affected communities. Large-…
Assessing racial and ethnic disparities using a COVID-19 outcomes continuum for New York State
…, MA Barranco, JM Tesoriero, DS Blog… - Annals of …, 2020 - Elsevier
Purpose Heightened COVID-19 mortality among Black non-Hispanic and Hispanic
communities (relative to white non-Hispanic) is well established. This study aims to estimate the …
communities (relative to white non-Hispanic) is well established. This study aims to estimate the …
COVID-19 testing, epidemic features, hospital outcomes, and household prevalence, New York State—March 2020
ES Rosenberg, EM Dufort, DS Blog… - Clinical Infectious …, 2020 - academic.oup.com
Background The US’ coronavirus disease 2019 (COVID-19) epidemic has grown extensively
since February 2020, with substantial associated hospitalizations and mortality; New York …
since February 2020, with substantial associated hospitalizations and mortality; New York …
[HTML][HTML] Candida auris in healthcare facilities, New York, USA, 2013–2017
…, V Haley, B Hutton, D Blog… - Emerging infectious …, 2018 - ncbi.nlm.nih.gov
Candida auris is an emerging yeast that causes healthcare-associated infections. It can be
misidentified by laboratories and often is resistant to antifungal medications. We describe an …
misidentified by laboratories and often is resistant to antifungal medications. We describe an …
[HTML][HTML] Mumps outbreak in Orthodox Jewish communities in the United States
…, P High, J Lawler, A Apostolou, D Blog… - … England Journal of …, 2012 - Mass Medical Soc
Background By 2005, vaccination had reduced the annual incidence of mumps in the United
States by more than 99%, with few outbreaks reported. However, in 2006, a large outbreak …
States by more than 99%, with few outbreaks reported. However, in 2006, a large outbreak …
Factors Associated With Candida auris Colonization and Transmission in Skilled Nursing Facilities With Ventilator Units, New York, 2016–2018
…, M Quinn, S Chaturvedi, D Blog… - Clinical Infectious …, 2021 - academic.oup.com
Background Candida auris is an emerging, multidrug-resistant yeast that spreads in healthcare
settings. People colonized with C. auris can transmit this pathogen and are at risk for …
settings. People colonized with C. auris can transmit this pathogen and are at risk for …
Laboratory analysis of an outbreak of Candida auris in New York from 2016 to 2018: impact and lessons learned
…, V Chaturvedi, RJ Limberger, D Blog… - Journal of clinical …, 2020 - Am Soc Microbiol
Candida auris is a multidrug-resistant yeast which has emerged in health care facilities
worldwide; however, little is known about identification methods, patient colonization, …
worldwide; however, little is known about identification methods, patient colonization, …
Zika virus testing considerations: lessons learned from the first 80 real-time reverse transcription-PCR-positive cases diagnosed in New York State
…, PB Backenson, D Kuhles, D Blog… - Journal of clinical …, 2017 - Am Soc Microbiol
The performance and interpretation of laboratory tests for Zika virus (ZKV) continue to be
evaluated. Serology is cross-reactive, laborious, and frequently difficult to interpret, and serum …
evaluated. Serology is cross-reactive, laborious, and frequently difficult to interpret, and serum …
